Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy.

about

Current progress in gene delivery technology based on chemical methods and nano-carriers Successful radiotherapy for repeated recurrent uterine clear cell adenocarcinoma.

P2860

Q28659480-8BA6611A-B934-4E34-A93C-272EC2E3E3F1 Q52991385-6A1E40C8-B9E0-4EF9-AB6A-BCF783C4132A

P2860

Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy.

Item

http://www.wikidata.org/entity/Q36555940

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Hypofractionated radiotherapy ...... lung cancer using Tomotherapy.

@ast

Hypofractionated radiotherapy ...... lung cancer using Tomotherapy.

@en

type

Item

label

Hypofractionated radiotherapy ...... lung cancer using Tomotherapy.

@ast

Hypofractionated radiotherapy ...... lung cancer using Tomotherapy.

@en

prefLabel

Hypofractionated radiotherapy ...... lung cancer using Tomotherapy.

@ast

Hypofractionated radiotherapy ...... lung cancer using Tomotherapy.

@en

P1476

Hypofractionated radiotherapy ...... lung cancer using Tomotherapy.

@en

P2093

Cheng-Yen Lee

http://www.w3.org/2001/XMLSchema#string

Heng-Jui Chang

http://www.w3.org/2001/XMLSchema#string

Hui-Ling Ko

http://www.w3.org/2001/XMLSchema#string

Jiunn-Song Jiang

http://www.w3.org/2001/XMLSchema#string

Kwan-Hwa Chi

http://www.w3.org/2001/XMLSchema#string

Ren-Hong Wu

http://www.w3.org/2001/XMLSchema#string

Shang-Jyh Kao

http://www.w3.org/2001/XMLSchema#string

Yu-Wung Yeh

http://www.w3.org/2001/XMLSchema#string

P2860

Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study

A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions.

Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head and neck schedules.

An overview of lung cancer genomics and proteomics.

Oligometastases and oligo-recurrence: the new era of cancer therapy.

Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.

Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?

The role of local therapy in the management of lung and liver oligometastases.

Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.

P2888

1748-717x-7-222

P304

222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-7-222

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233994537

http://www.w3.org/2001/XMLSchema#string

P6179

1018067231

http://www.w3.org/2001/XMLSchema#string

P698

23268786

http://www.w3.org/2001/XMLSchema#string

P932

3552755

http://www.w3.org/2001/XMLSchema#string

Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy.

about

P2860

P2860

Hypofractionated radiotherapy for primary or secondary oligometastatic lung cancer using Tomotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932